MTD icon

Mettler-Toledo International

1,273.96 USD
-2.14
0.17%
At close Updated Sep 17, 4:00 PM EDT
Pre-market
After hours
1,273.96
0.00
0%
1 day
-0.17%
5 days
2.33%
1 month
-2.85%
3 months
10.72%
6 months
3.15%
Year to date
4.36%
1 year
-7.92%
5 years
29.52%
10 years
320.25%
 

About: Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (around 55% of sales), industrial (around 40%), and food retail (around 5%) industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with the Americas accounting for about 37% of sales, Europe about 28%, China about 16% and the rest of the world about 19%.

Employees: 17,300

0
Funds holding %
of 7,463 funds
0
Analysts bullish %
of 5 analysts

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

436% more call options, than puts

Call options by funds: $286M | Put options by funds: $53.4M

4.8% more ownership

Funds ownership: 95.37% [Q1] → 100.17% (+4.8%) [Q2]

4% more capital invested

Capital invested by funds: $23.4B [Q1] → $24.5B (+$1.01B) [Q2]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q1] → 1 (+0) [Q2]

2% less repeat investments, than reductions

Existing positions increased: 276 | Existing positions reduced: 283

4% less funds holding

Funds holding: 803 [Q1] → 774 (-29) [Q2]

17% less first-time investments, than exits

New positions opened: 79 | Existing positions closed: 95

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$1,230
3% downside
Avg. target
$1,338
5% upside
High target
$1,600
26% upside

5 analyst ratings

positive
60%
neutral
40%
negative
0%
Citigroup
Patrick Donnelly
$1,600
Buy
Maintained
21 Aug 2025
Evercore ISI Group
Vijay Kumar
$1,275
Outperform
Maintained
4 Aug 2025
Baird
Catherine Schulte
$1,230
Neutral
Maintained
4 Aug 2025
B of A Securities
Derik De Bruin
$1,260
Neutral
Maintained
26 Jun 2025
Barclays
Luke Sergott
$1,325
Overweight
Initiated
24 Jun 2025

Financial journalist opinion

Positive
Zacks Investment Research
1 month ago
Should You Buy Mettler-Toledo (MTD) After Golden Cross?
Mettler-Toledo International, Inc. (MTD) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, MTD's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross.
Should You Buy Mettler-Toledo (MTD) After Golden Cross?
Positive
Zacks Investment Research
1 month ago
Mettler-Toledo (MTD) is a Top-Ranked Growth Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Mettler-Toledo (MTD) is a Top-Ranked Growth Stock: Should You Buy?
Positive
Zacks Investment Research
1 month ago
Here's Why Mettler-Toledo (MTD) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Mettler-Toledo (MTD) is a Strong Momentum Stock
Neutral
Business Wire
1 month ago
Pablo Perversi to Join METTLER TOLEDO Board of Directors
COLUMBUS, Ohio--(BUSINESS WIRE)--Mettler-Toledo International Inc. (NYSE: MTD) announced today that Pablo Perversi has been appointed to its Board of Directors, effective November 6, 2025. Mr. Perversi is the President of Europe at Danone, a leading global food and beverage company, and a member of its Executive Committee. Prior to his current role, Pablo served as Chief Innovation, Quality, and Sustainability Officer and President of Gourmet Division for Barry Callebaut from 2017 to 2022. Befo.
Pablo Perversi to Join METTLER TOLEDO Board of Directors
Positive
Seeking Alpha
1 month ago
Mettler-Toledo: With Margins As Good As ASML, Similarities Abound
I maintain a buy rating on Mettler-Toledo, highlighting its capital-light, high-cash-generating model and dominant market position. Recent tariff surprises are non-issue; their impact is marginal and easily offset by MTD's efficiency and strong gross margins. MTD's sustained outperformance is driven by relentless efficiency, disciplined capital allocation, and a sticky, high-margin service business.
Mettler-Toledo: With Margins As Good As ASML, Similarities Abound
Positive
The Motley Fool
1 month ago
Mettler-Toledo (MTD) Q2 EPS Jumps 5%
Mettler-Toledo (MTD) Q2 EPS Jumps 5%
Mettler-Toledo (MTD) Q2 EPS Jumps 5%
Positive
Zacks Investment Research
1 month ago
Mettler-Toledo (MTD) Reports Q2 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Mettler-Toledo (MTD) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Mettler-Toledo (MTD) Reports Q2 Earnings: What Key Metrics Have to Say
Neutral
Seeking Alpha
1 month ago
Mettler-Toledo International Inc. (MTD) Q2 2025 Earnings Call Transcript
Mettler-Toledo International Inc. (NYSE:MTD ) Q2 2025 Earnings Conference Call August 1, 2025 8:30 AM ET Company Participants Adam William Uhlman - Head of Investor Relations Patrick K. Kaltenbach - President & CEO Shawn P.
Mettler-Toledo International Inc. (MTD) Q2 2025 Earnings Call Transcript
Positive
Zacks Investment Research
1 month ago
Mettler-Toledo (MTD) Q2 Earnings and Revenues Top Estimates
Mettler-Toledo (MTD) came out with quarterly earnings of $10.09 per share, beating the Zacks Consensus Estimate of $9.58 per share. This compares to earnings of $9.65 per share a year ago.
Mettler-Toledo (MTD) Q2 Earnings and Revenues Top Estimates
Positive
Reuters
1 month ago
Mettler-Toledo raises annual profit forecast on strong demand for lab instruments
Mettler-Toledo International raised its profit forecast for the year on Thursday, after posting better-than-expected second-quarter results, driven by strong demand for its laboratory instruments used in drug development.
Mettler-Toledo raises annual profit forecast on strong demand for lab instruments
Charts implemented using Lightweight Charts™